H-3 IMIPRAMINE BINDING TO PREVIOUSLY FROZEN PLATELET MEMBRANES FROM DEPRESSED-PATIENTS, BEFORE AND AFTER TREATMENT

被引:23
作者
HEALY, D
THEODOROU, AE
WHITEHOUSE, AM
LAWRENCE, KM
WHITE, W
WILTONCOX, H
KERRY, SM
HORTON, RW
PAYKEL, ES
机构
[1] ST GEORGE HOSP, SCH MED, DEPT PHARMACOL & CLIN PHARMACOL, LONDON SW17 0RE, ENGLAND
[2] UNIV CAMBRIDGE, DEPT PSYCHIAT, CAMBRIDGE, ENGLAND
关键词
D O I
10.1192/bjp.157.2.208
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
3H-imipramine binding in 39 drug-free patients with major depression and 44 healty controls did not differ significantly between the two groups, in male or female subjects or in subgroups of depressed patients divided by endogenicity or dexamethasone suppression test result. 3H-imipramine binding in depressed patients drug-free for less than three weeks did not differ from those drug-free for longer intervals or from controls. A significant seasonal variation of 3H-imipramine Bmax was found, with lower values in summer and autumn. Treatment of depressed patients with imipramine or lofepramine for six weeks increased K(D) and Bmax. Methodological modification (in preparation and storage of platelets) does not explain the major differences in results between this study (using frozen platelets), a previous one (using freshly prepared platelets) and others in general, although it might contribute to the range of values reported.
引用
收藏
页码:208 / 215
页数:8
相关论文
共 45 条
[1]   EFFECT OF PROTEIN-CONCENTRATION ON KINETIC CONSTANTS (KD AND BMAX) OF H-3-IMIPRAMINE BINDING IN BLOOD-PLATELETS [J].
ARORA, RC ;
WUNNICKE, V ;
MELTZER, HY .
BIOLOGICAL PSYCHIATRY, 1985, 20 (01) :116-119
[2]  
ARORA RC, 1984, BIOL PSYCHIAT, V19, P257
[3]   EFFECT OF DESIPRAMINE TREATMENT ON H-3-IMIPRAMINE BINDING IN THE BLOOD-PLATELETS OF DEPRESSED-PATIENTS [J].
ARORA, RC ;
MELTZER, HY .
BIOLOGICAL PSYCHIATRY, 1988, 23 (04) :397-404
[4]  
BARON M, 1986, AM J PSYCHIAT, V143, P711
[5]   WHO PILOT-STUDY ON THE VALIDITY OF IMIPRAMINE PLATELET RECEPTOR-BINDING SITES AS A BIOLOGICAL MARKER OF ENDOGENOUS-DEPRESSION - A PRELIMINARY-REPORT ON THE INITIAL EVALUATION PHASE OF A WORLD-HEALTH-ORGANIZATION COLLABORATIVE STUDY [J].
BECH, P ;
EPLOV, L ;
GASTPAR, M ;
GENTSCH, C ;
MENDLEWICZ, J ;
PLENGE, P ;
RIELAERT, C ;
MELLERUP, ET .
PHARMACOPSYCHIATRY, 1988, 21 (03) :147-150
[6]   BINDING OF YOHIMBINE AND IMIPRAMINE TO PLATELETS IN DEPRESSIVE-ILLNESS [J].
BRADDOCK, L ;
COWEN, PJ ;
ELLIOTT, JM ;
FRASER, S ;
STUMP, K .
PSYCHOLOGICAL MEDICINE, 1986, 16 (04) :765-773
[7]   CHANGES IN THE BINDING TO PLATELETS OF [H-3]IMIPRAMINE AND [YOHIMBINE-H-3 IN NORMAL SUBJECTS TAKING AMITRIPTYLINE [J].
BRADDOCK, LE ;
COWEN, PJ ;
ELLIOTT, JM ;
FRASER, S ;
STUMP, K .
NEUROPHARMACOLOGY, 1984, 23 (2B) :285-286
[8]   TRITIATED IMIPRAMINE BINDING-SITES ARE DECREASED IN PLATELETS OF UNTREATED DEPRESSED-PATIENTS [J].
BRILEY, MS ;
LANGER, SZ ;
RAISMAN, R ;
SECHTER, D ;
ZARIFIAN, E .
SCIENCE, 1980, 209 (4453) :303-305
[9]   THE DIAGNOSIS OF DEPRESSIVE SYNDROMES AND THE PREDICTION OF ECT RESPONSE [J].
CARNEY, MWP ;
ROTH, M ;
GARSIDE, RF .
BRITISH JOURNAL OF PSYCHIATRY, 1965, 111 (475) :659-674
[10]   IMIPRAMINE BINDING-SITES ON PLATELETS OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER [J].
CARSTENS, ME ;
ENGELBRECHT, AH ;
RUSSELL, VA ;
AALBERS, C ;
GAGIANO, CA ;
CHALTON, DO ;
TALJAARD, JJF .
PSYCHIATRY RESEARCH, 1986, 18 (04) :333-342